Age has no influence on mobilization of peripheral blood stem cells in acute myeloid leukemia
- 16 March 2007
- journal article
- Published by Wiley in Hematological Oncology
- Vol. 25 (2) , 84-89
Abstract
The upper age limit for autologous stem cell transplantation (ASCT) in acute myeloid leukemia (AML) is increasing and peripheral blood (PB) represents the standard source of stem cell (SC). However, no data are available on the impact of age on SC mobilization in AML. We analyzed a cohort of 150 consecutive AML patients in first complete remission in order to make a comparison between patients up to 60 years and above 60 years, by evaluating CD34+ cells mobilization into PB and the number of leukapheresis needed to collect at least one single SC graft. The successful mobilization rate (>2 × 106 CD34+ cells/kg) was comparable between the two groups (87% vs. 80%, p = 0.29). In addition, no statistically significant difference was found in terms of either median number of CD34+ cells collected (p = 0.54) or CD34+ cells peak in PB (p = 0.70). Both groups of patients needed a median of two apheresis and no difference was found in the median number of CD34+ cells collected per single apheresis (p = 0.67). Finally, no correlation was found between age and total number of CD34+ cells collected (r = 0.003, p = 0.58). We conclude that age has no impact on mobilization of PBSCs in AML. Copyright © 2007 John Wiley & Sons, Ltd.Keywords
This publication has 35 references indexed in Scilit:
- Long-term Outcome of Autologous Transplantation of Peripheral Blood Progenitor Cells as Postremission Management of Patients ≥60 Years with Acute Myelogenous LeukemiaTransplantation and Cellular Therapy, 2006
- Mobilizing the older patient with myelomaBlood Reviews, 2006
- Cardiovascular toxicity is increased, but manageable, during high-dose chemotherapy and autologous peripheral blood stem cell transplantation for patients aged 60 years and olderLeukemia & Lymphoma, 2005
- Factors affecting PBSC mobilization and collection in healthy donorsTransfusion and Apheresis Science, 2005
- Factors for PBPC collection efficiency and collection predictorsTransfusion and Apheresis Science, 2004
- Continuous infusion idarubicin and oral busulfan as conditioning for patients with acute myeloid leukemia aged over 60 years undergoing autologous stem cell transplantationBone Marrow Transplantation, 2004
- Unanswered questions in acute myeloid leukaemiaThe Lancet Oncology, 2004
- Purine Nucleoside Analogues in the Treatment of Myleoid LeukemiasLeukemia & Lymphoma, 2003
- Transplant-related mortality in patients older than 60 years undergoing autologous hematopoietic stem cell transplantationBone Marrow Transplantation, 2001
- Feasibility and recent improvement of autologous stem cell transplantation for acute myelocytic leukaemia in patients over 60 years of age: importance of the source of stem cellsBritish Journal of Haematology, 2000